Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Xiaflex market launch year?Does lipitor's effectiveness decrease with high fat meals?Diltiazem drug class?How does trastuzumab emtansine's patent expiry affect drug prices?When genetic tenofovir alafenamide be available in us?
See the DrugPatentWatch profile for uzedy
UZEDY (risperidone) extended-release injection is available in two dosing schedules: monthly or every two months. Patients start with a monthly injection, then switch to every-two-months after at least two monthly doses if stable.[1]
Eligibility requires stability on the prior monthly regimen, confirmed by a healthcare provider. The every-two-month option uses higher-strength formulations (e.g., 250 mg/2 mL or 375 mg/2 mL) for equivalent exposure over the longer interval.[1]
| Schedule | Injection Strengths | |----------------|--------------------------------------| | Monthly | 50 mg/0.14 mL, 75 mg/0.21 mL, 100 mg/0.28 mL, 125 mg/0.35 mL, 150 mg/0.42 mL, 200 mg/0.56 mL, 250 mg/0.7 mL | | Every 2 Months| 250 mg/2 mL, 375 mg/2 mL |[1]
The every-two-month dosing reduces injection frequency for adherent patients with schizophrenia, improving convenience while maintaining steady risperidone levels via subcutaneous delivery.[1] Sources [1]: UZEDY Prescribing Information (Teva Pharmaceuticals)
Other Questions About Uzedy :